Evidence Updates

Did Kidney Function Change, or Did the eGFR Equation Change?

Audit an eGFR trend across a laboratory-equation change and distinguish indexed from absolute estimates before inferring kidney injury, recovery or a dosing decision.

Quick Medical Calculator Editorial Team · Reading label · 4 min read

Retrospective study sequence, not publication date

Editorial record

This source-linked educational article has been updated through AI-assisted evidence checks and editorial review. Verify information against current guidance and local protocols before applying it to patient care.

Citation methodology

A discontinuity in an eGFR chart can reflect a laboratory-method change rather than an abrupt biological change. This matters when reviewing CKD progression, eligibility thresholds, or medication decisions.

The 2021 Equation Was Refit, Not Just Relabeled

The 2021 CKD-EPI work developed new race-free equations using creatinine alone and creatinine with cystatin C. Simply deleting the race multiplier from an older equation does not reproduce the new model. The development study found different patterns of bias across groups; it did not establish identical performance in every population. Inker and colleagues.

MDRD, 2009 CKD-EPI, and 2021 CKD-EPI results should therefore not be spliced into a trend without identifying the equation. A change in the reported number is not, by itself, evidence of injury or recovery.

A Practical Trend Audit

For a fictional patient whose creatinine is unchanged but whose reported eGFR changes when the laboratory adopts a new equation:

  1. Obtain the actual creatinine values, dates, units, and laboratory method.
  2. Confirm the old and new equation names, including whether one combines creatinine and cystatin C.
  3. Where appropriate, recalculate comparable historical values using one equation, preserving the original reports rather than overwriting them.
  4. Review albuminuria, clinical context, and repeat measurements before labeling progression.

The purpose is to distinguish analytical and model changes from a biological trend. No fixed "3-9 mL/min" adjustment works for all patients. CKD-EPI 2021 is widely used in US adult practice, but KDIGO calls for a validated equation appropriate to the population, not an assertion that one formula is best everywhere. KDIGO 2024, GFR evaluation.

A Second Mismatch: Indexed Versus Absolute GFR

For a separate fictional patient with reported eGFR 45 mL/min/1.73 m2 and body surface area 2.20 m2:

Absolute estimate = 45 x 2.20 / 1.73 = 57.23 mL/min

The two numbers express different scaling of the same estimate. Do not call the larger number an improvement in kidney function. BSA adjustment can matter for drug dosing at body-size extremes; the medicine's label and relevant dosing guidance determine which estimate is appropriate. De-indexing does not turn eGFR into Cockcroft-Gault creatinine clearance. NIDDK drug-dosing guidance.

Do Not Generalize From One Validation Cohort

A study of 415 stable kidney transplant recipients found broadly similar performance between old and new CKD-EPI equations, but 87% of participants were White and few had measured GFR below 30. This supports a bounded conclusion in that sample, not universal equivalence. Hundemer and colleagues.

Kidney-Function Handover: A Checklist for the Medicines Review

Retrospective educational series: 17 September to 16 October 2026. This coverage window is not the publication date.

When the Handover Says Only "Renal Function 47"

In this fictional medicines-review handover, the only supplied information is "renal function 47". No unit, equation, specimen date or medicine indication is stated. Do not infer that the number is creatinine clearance, indexed eGFR or a quantity ready to use in a medicine's renal advice.

Use the following reconciliation note to make the unresolved questions visible:

QuestionWhat the Handover Should Contain
Which product and indication?The exact medicine, formulation, indication and current product-information version.
Which quantity does its renal advice request?The original term and unit, including any named estimation method and body-size indexing.
What did the laboratory actually report?Specimen date, equation, units and the original result, not just a copied number.
Was another estimate calculated?Its inputs and method. Document BSA adjustment or CrCl weight convention explicitly rather than relabelling the laboratory result.
Is the estimate clinically interpretable now?Whether kidney function is changing and whether creatinine-based estimation is appropriate. Record who will resolve remaining uncertainty.

NIDDK describes the differing kidney measures behind medicine labels and the limitations of creatinine-based estimates. Additional assessment may be appropriate when an estimate is unreliable or a decision is near a boundary. This does not justify substituting a convenient calculator for the method required by the applicable product information and local medicines policy. NIDDK guidance.

The creatinine-clearance calculator and CKD-EPI calculator do not estimate interchangeable quantities. Neither selects a product-specific dose.

Close the handover with a resolved question, not an extra decimal place. If the required quantity or the validity of the estimate remains uncertain, document that and obtain appropriate medicines or renal advice. This checklist intentionally provides no drug-specific threshold, dose or equation-to-equation substitution rule.

Reading label: 22 September 2026. Day 6 of the retrospective educational series. This is a reading-sequence date, not a publication or clinical-review date.

Related calculators